Speak First is all about three things – confidence, impact and clarity. Our communication skills training and coaching is guaranteed to enhance business relationships. With over 20 years’ experience, we are global specialists in soft skills training essential for business success. Our expertise include: presentation skills, personal impact, media training, selling and negotiation skills, business writing, NLP for Business and other interpersonal and communication skills training to improve workplace effectiveness and career success.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
AMICULUM works with the global healthcare industry to bring science to life across the product lifecycle from early opportunity assessment through to launch and beyond. By listening to the changing…
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education to life science companies from around the globe since 2008.
M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an…
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.
Company Details
Latest Content from PMHub
Press Releases | September 30, 2025 | Medscape Education
UPPER NYACK, N.Y.--(BUSINESS WIRE)--The Global Healthy Living Foundation (GHLF) today announced a new partnership with Medscape Education to advance patient-centered innovation within the Immunology Learning Nexus (Nexus), Medscape’s flagship multi-year...
Press Releases | September 24, 2025 | Inizio
Inizio has appointed Mary-Kate McGarry as Chief Strategy & Innovation Officer and Gavin McShera as Chief Information Officer, strengthening its executive leadership to drive innovation, digital transformation, and Intelligent Commercialization™...
Press Releases | September 24, 2025 | Inizio
Inizio has been named a finalist in six categories at the 2025 PM360 Trailblazer Awards, recognizing its teams’ excellence in AI, data analytics, education, patient engagement, and industry partnership across...
Press Releases | September 24, 2025 | Inizio
Inizio experts contribute to Forbes’ Voices of Oncology, highlighting our commitment to driving innovation in cancer care through advanced data analytics, cross-sector collaboration, and real-world impact for patients.
Press Releases | September 22, 2025 | Medscape Education
Analysis from Komodo Health and Medscape Education shows cognitive screening up 10% and biomarker testing up 23%, yet significant disparities persist in detection for women and treatment access for Black...
Press Releases | September 19, 2025 | CMI Media Group
PHILADELPHIA, PA – Strategic media healthcare agencies CMI Media Group & Compas, a WPP company (NYSE: WPP), are proud to be Certified™ by Great Place To Work® for the third year in...
Press Releases | September 19, 2025 | CMI Media Group
Matt Durham, VP, Global, anticipated pharma’s global media boom. Now he’s leading CMI Media Group’s push to broaden its market coverage. This new profile article focusing on Global VP Matt...
Press Releases | September 19, 2025 | CMI Media Group
The ASCO Conference has a global impact; a new PharmiWeb byline by Calum Griffin, Senior Global Engagement Planner inspired by the conference shares that the pharma marketing landscape has radically...
Press Releases | September 18, 2025 | Genetic Digital
Genetic Digital wins Silver at the PM Society Digital Awards for Epilepsy Meds, a clinical support app developed with Desitin and ChangeMed to aid patient-specific prescribing in epilepsy care.
Press Releases | September 17, 2025 | Innovative Trials
Kate Shaw comments on the latest news about AstraZeneca and Merck's decision to hold planned investments in the UK